Full video transcriptClick to expand
Auto-generated transcript of @narellan.medical.s's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Are you a woman struggling with low libido and it's severely affecting the quality of
- 0:05your relationship with your partner and you've tried everything to revive it?
- 0:09Then this video is for you because most women have no idea that they might need testosterone
- 0:16and the ones who do need it, they've been suffering in silence for years.
- 0:19I'm Dr Anna Pham, I'm a GP who specializes in women's health and I run medical practices
- 0:24in South West Sydney.
- 0:25And today I need to talk about something that's really discussed but could change everything
- 0:31for some of you.
- 0:32Testosterone supplementation for women.
- 0:34Here's what happens in my clinic almost weekly.
- 0:37For women comes in, she's tried everything for her low libido.
- 0:40She's optimized her sleep, she's managing stress, her relationship is good but something
- 0:45is still missing.
- 0:46She feels like there's something wrong with her.
- 0:49Her partner may be frustrated, she's frustrated and she's starting to think that this is
- 0:54just her new normal.
- 0:55But here's what most people don't know.
- 0:58Women produce testosterone too, not as much as men but it's absolutely crucial for alibido,
- 1:03energy and overall sense of wellbeing.
- 1:05So replacing testosterone is something that I consider as a doctor.
- 1:09When do I actually consider testosterone for women?
- 1:12It's when low libido is genuinely affecting their intimate relationships and quality of
- 1:17life and we've ruled out other courses.
- 1:20I'm not talking about just feeling a bit tired, I'm talking about women who tell me
- 1:24their lack of desire is creating real problems in their marriage or relationship.
- 1:29Now in Australia we're lucky to have something called Andrifam.
- 1:33It's a testosterone cream specifically formulated for women.
- 1:36Low dose, applied daily has been life changing for many of my patients.
- 1:41You might have heard about testosterone injections for women but in Australia we don't do this.
- 1:46The cream gives us much better control and significantly reduces side effects.
- 1:51But listen carefully, this is not something you experiment with on your own.
- 1:57Testosterone needs proper medical supervision, baseline testing and ongoing monitoring.
- 2:03The women who typically benefit most are those going through menopause or pyrometopause
- 2:08where their natural testosterone has dropped significantly.
- 2:11Now remember, this is general advice only.
- 2:14If low libido is genuinely impacting your relationship and your happiness, have an honest
- 2:20conversation with your own GP about whether Lotus Docerone is worth exploring as a cause
- 2:26for your low libido.
- 2:27If you would like to speak to me or one of the doctors in our practice, find the link in
- 2:31the bio.
Does low libido in women come down to hormones?
Quick answer
Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al., Journal of Sexual Medicine) recommending it following a thorough clinical assessment and after excluding other contributing causes. Androfem is used off-label in Australia for this purpose and requires baseline hormonal testing, dosing oversight, and ongoing monitoring for androgenic side effects including acne, hirsutism, and voice changes. Evidence for testosterone improving energy or general wellbeing independent of sexual function remains inconsistent and should not be presented as established benefit.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does low libido in women come down to hormones?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Does low libido in women come down to hormones? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Does low libido in women come down to hormones?" from Narellan Medical + Skin. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al.
The reason this review is not generic is the source wording and the canonical claim label "trt low libido and no one talks about it you ve fixed your sleep." In this clip, the useful excerpt is: "Are you a woman struggling with low libido and it's severely affecting the quality of your relationship with your partner and you've tried everything to revive it?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al., Journal of Sexual Medicine) recommending it following a thorough clinical assessment and after excluding other contributing causes. Androfem is used off-label in Australia for this purpose and requires baseline hormonal testing, dosing oversight, and ongoing monitoring for androgenic side effects including acne, hirsutism, and voice changes. Evidence for testosterone improving energy or general wellbeing independent of sexual function remains inconsistent and should not be presented as established benefit.
- The 2019 Global Consensus Position Statement, backed by over 40 RCTs, supports testosterone therapy for HSDD in postmenopausal women, making this a legitimate clinical tool, not a fringe intervention.
- Evidence for testosterone improving energy or mood in women is inconsistent. A 2014 Cochrane review found no reliable benefit outside of sexual function, so claims about general wellbeing should be treated with skepticism.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The 2019 Global Consensus Position Statement, backed by over 40 RCTs, supports testosterone therapy for HSDD in postmenopausal women, making this a legitimate clinical tool, not a fringe intervention.
- Evidence for testosterone improving energy or mood in women is inconsistent. A 2014 Cochrane review found no reliable benefit outside of sexual function, so claims about general wellbeing should be treated with skepticism.
- Androfem is used off-label in Australia for female HSDD. It is not TGA-approved specifically for this indication, which is something patients should be told before starting treatment.
- Even low-dose transdermal testosterone can cause acne, increased body hair, and, at elevated doses, irreversible voice deepening. Monitoring testosterone levels is not optional, it is how you avoid harm.
- Thyroid dysfunction, iron deficiency anaemia, and SSRI or SNRI use are common and underdiagnosed causes of low libido in women. These should be excluded before attributing symptoms to testosterone deficiency.
- The transcript includes an apparent verbal slip referencing 'Lotus Docerone,' which is not a recognized clinical term. Viewers searching this term will find nothing, and the confusion could delay someone getting appropriate care.
- Self-treating with testosterone products purchased outside a regulated medical pathway carries real risks including dosing errors, contamination, and no monitoring. A GP consultation is the appropriate first step.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @narellan.medical.s actually say?
Dr Anna Pham, a GP based in South West Sydney, argues that many women with persistent low libido may have undiagnosed low testosterone, and that testosterone supplementation, specifically a cream called Androfem, can be genuinely life-changing. She frames it as a last resort after sleep, stress, and relationship factors have been ruled out, and insists on medical supervision, baseline testing, and ongoing monitoring before anyone starts. She also clarifies that Australia does not use testosterone injections for women, preferring cream for dose control and a lower side-effect profile.
She name-drops "Lotus Docerone" near the end, which appears to be a mispronunciation or verbal slip, likely meaning low-dose testosterone. It is worth flagging because a viewer might search that term and find nothing useful.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Narellan Medical + Skin · TikTok creator
6.3K views on this video
Low libido… and no one talks about it? You’ve fixed your sleep. Managed the stress. The relationship is solid. But the desire just isn’t there. For some women, it’s not “in your head.” It’s hormones. #narellan #womenshealth #lowlibido ----- The information contained in this video and across all content is general advice. It is best to consult with your doctor for your specific needs.
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the 2019 global consensus position statement, backed by over 40?
The 2019 Global Consensus Position Statement, backed by over 40 RCTs, supports testosterone therapy for HSDD in postmenopausal women, making this a legitimate clinical tool, not a fringe intervention.
What does the video say about evidence for testosterone improving energy?
Evidence for testosterone improving energy or mood in women is inconsistent. A 2014 Cochrane review found no reliable benefit outside of sexual function, so claims about general wellbeing should be treated with skepticism.
What does the video say about androfem?
Androfem is used off-label in Australia for female HSDD. It is not TGA-approved specifically for this indication, which is something patients should be told before starting treatment.
What does the video say about even low-dose transdermal testosterone can cause acne, increased body hair,?
Even low-dose transdermal testosterone can cause acne, increased body hair, and, at elevated doses, irreversible voice deepening. Monitoring testosterone levels is not optional, it is how you avoid harm.
What does the video say about thyroid dysfunction, iron deficiency anaemia,?
Thyroid dysfunction, iron deficiency anaemia, and SSRI or SNRI use are common and underdiagnosed causes of low libido in women. These should be excluded before attributing symptoms to testosterone deficiency.
What does the video say about the transcript includes an apparent verbal slip referencing 'lotus docerone,'?
The transcript includes an apparent verbal slip referencing 'Lotus Docerone,' which is not a recognized clinical term. Viewers searching this term will find nothing, and the confusion could delay someone getting appropriate care.
Not medical advice. This video was made by Narellan Medical + Skin, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.